These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1186467)

  • 21. [Study of plasma aldosterone in patients on chronic hemodialysis].
    Dordević V; Kostić S; Stefanović V
    Acta Med Iugosl; 1986; 40(1):49-55. PubMed ID: 3515862
    [No Abstract]   [Full Text] [Related]  

  • 22. Response of plasma aldosterone to sequential ultrafiltration, dialysis and conventional hemodialysis.
    Farinelli A; Squerzanti R; De Paoli Vitali E; Bagni B; Cavallini AR; Gilli P; Bedani PL
    Nephron; 1980; 26(6):274-9. PubMed ID: 7005702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in aldosterone level and renin activity of blood of patients on programmed hemodialysis].
    Lifshits NL; Ermolenko VM; Tatsievskiĭ VA; Khu LCh
    Ter Arkh; 1979; 51(11):67-72. PubMed ID: 524286
    [No Abstract]   [Full Text] [Related]  

  • 24. Control of plasma aldosterone concentration during hemodialysis.
    Read VH; McCaa CS; Bower JD; McCaa RE
    Proc Clin Dial Transplant Forum; 1972; 2():93-9. PubMed ID: 4619676
    [No Abstract]   [Full Text] [Related]  

  • 25. Vasoactive hormones in children with chronic renal failure.
    Rauh W; Hund E; Sohl G; Rascher W; Mehls O; Schärer K
    Kidney Int Suppl; 1983 Nov; 15():S27-33. PubMed ID: 6368949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Falsely elevated plasma aldosterone concentration by direct radioimmunoassay in chronic renal failure.
    Koshida H; Miyamori I; Miyazaki R; Tofuku Y; Takeda R
    J Lab Clin Med; 1989 Sep; 114(3):294-300. PubMed ID: 2769019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
    Arrizabalaga P; Montoliu J; Martinez Vea A; Andreu L; López Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 20():572-6. PubMed ID: 6318223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sodium and potassium concentration in the erythrocytes of patients undergoing chronic hemodialysis. (II).--Effects of extracellular fluid sodium concentration on the erythrocytes sodium and potassium concentration (author's transl)].
    Imada A; Horiuchi A; Kawauchi Y; Kogi Y
    Rinsho Byori; 1982 Feb; 30(2):199-203. PubMed ID: 7087241
    [No Abstract]   [Full Text] [Related]  

  • 29. Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis.
    Ivić M; Strahinjić S; Stefanović V
    Acta Med Iugosl; 1987; 41(3):205-13. PubMed ID: 3661237
    [No Abstract]   [Full Text] [Related]  

  • 30. The red cell sodium, potassium, inorganic phosphate, ATP and 2,3DPG concentrations in chronic renal failure.
    Jabłońska-Skwiecinśka E; Staniszewska K; Kowalska H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):493-5. PubMed ID: 2446986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactinemia during hemodialysis: lack of correlation with sodium, potassium and renin-aldosterone system.
    Sciarra F; Sparano F; Giaquinto G; Odoardi A; Mercuri MA; Concolino G
    Horm Res; 1977; 8(3):129-38. PubMed ID: 903075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diurnal variation of urinary potassium excretion in chronic renal insufficiency.
    Hishida A; Honda N; Kumagai H; Sudo M; Nagase M
    Miner Electrolyte Metab; 1982 Jan; 7(1):20-7. PubMed ID: 6763141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of plasma aldosterone concentration by plasma potassium in anephric man in the absence of a change in potassium balance.
    Cooke CR; Horvath JS; Moore MA; Bledsoe T; Walker WG
    J Clin Invest; 1973 Dec; 52(12):3028-32. PubMed ID: 4750439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of extracorporeal dialysis on plasma renin activity in patients with acute and chronic renal failure.
    Kokot F; Kuska J
    Pol Med J; 1972; 11(5):1070-9. PubMed ID: 4648592
    [No Abstract]   [Full Text] [Related]  

  • 37. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activity of plasma renin and plasma aldosterone in terminal renal failure].
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Reck G; Siegenthaler W
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1799-801. PubMed ID: 4456599
    [No Abstract]   [Full Text] [Related]  

  • 39. The renin-angiotensin-aldosterone system during haemodialysis with acetate or bicarbonate at different dialysate sodium concentrations.
    Krämer BK; Ress KM; Ulshöfer TM; Risler T
    Nephrol Dial Transplant; 1987; 2(6):531-6. PubMed ID: 3126454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.